Our next step of the research is to generate a murine counter part of CAR‐T cells with murine scFv‐IL‐13Rα2 as a transgene and test its quality attributes in vitro and in vivo in syngeneic mouse models using murine IL‐13Rα2 positive glioma cell lines such as GL121 and CTA2. Here, IL13RA2 is linked to glioma.